Pfizer hails Ireland as ‘industrial powerhouse’ in life sciences
Albert Bourla, chief executive of US pharma giant, accepts IDA Ireland’s Special Recognition Award on behalf of the company
Albert Bourla
BioNTech/Pfizer’s mooted EU deal for 70m Covid shots threatens rivals
European health officials have advocated portfolio diversity to help fight different variants
Pfizer to seek approval of Covid vaccine for under 5s
Interim results from its clinical trial showed the jab is safe and highly effective, company said
Pfizer disappoints with unchanged Covid sales forecasts
Vaccine and Covid pill account for half of sales in first quarter of the year
Chief executives of mRNA vaccine groups earn $100m in pandemic pay
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
EU Commission accused of maladministration by ombudsman over Pfizer CEO texts
Emily O’Reilly criticises executive for not disclosing Von Der Leyen messages
Repeated boosters of existing Covid vaccines is not a sustainable strategy, WHO warns
Health experts call for new jabs that better protect against coronavirus transmission
Booster shot neutralises Omicron, Pfizer and BioNTech say
Third vaccine dose as effective as second shot was in fighting original virus, study finds
Covid vaccine boosters will likely be needed every year, Pfizer chief says
New jab for Omicron variant of coronavirus being developed, Dr Albert Bourla says
Omicron: EU states urged to boost genome sequencing as Ireland lags behind
Moderna chief warns existing vaccines will struggle with latest coronavirus variant
Pfizer to produce coronavirus pill at Ringaskiddy plant
Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant
Biden urges vaccine mandates for workers after Pfizer jab approved
US employers increasingly seeking proof of full vaccination from staff and customers
US regulator grants full approval to Pfizer’s Covid vaccine
Officials hope move will convince more unvaccinated Americans shot is safe and effective
Pfizer’s vaccine kingpin: ‘If mRNA had failed, we would be in a very difficult spot right now’
The pharma boss on the group's Covid jab and his exchanges with Trump
BioNTech profits soar as Covid vaccine demand surges
German company announces plans to test its efficacy in children under 12 and pregnant women
Pfizer and Moderna ramp up EU Covid vaccine prices
Deal struck as EU worried about supplies and side effects of other vaccines
US to donate 500m Pfizer Covid-19 vaccine doses globally, sources say
Shots will be distributed to 92 lower-income countries through COVAX programme
Will patent waiver really deliver Covid vaccine worldwide?
Cantillon: Balancing costs of research and needs of poorer countries is a challenge
Covid-19 booster shot ‘likely’ needed within year, Pfizer chief says
Annual revaccinations, similar to flu shots, possible as virus variants emerge
BioNTech and Pfizer trial data suggests vaccine protects against South Africa variant
Johnson & Johnson assures on production targets despite ruined batch
Israel Covid rate down 96% among those who received both Pfizer shots
World round-up: Argentinian minister told to resign after organising vaccine for journalist
Pfizer expects €12.5bn in Covid vaccine revenue this year
Pharma group raises forecasts on back of J&J rival’s efficacy and AstraZeneca woes
Netanyahu says all Israeli adults will be vaccinated before April
PM says deal agreed with Pfizer-BioNTech for vaccine delivery as harder lockdown begins
‘It’s being treated like a war’: Israel’s rapid Covid-19 vaccination drive
Country’s move to rapidly inoculate population helped to change public mood
World first as UK approves Pfizer-BioNTech Covid-19 vaccine
Vaccine could begin roll-out from early next week
Pfizer/BioNTech Covid-19 vaccine is 95% effective with no serious side effects
Companies hold out prospect of December deliveries
Councils overpaying for social housing, rise in private pension age, and businesses unprepared for Brexit
Business Today: the best news, analysis and comment from The Irish Times business desk
Pfizer eyes vaccine green light after passing key safety point
Company preparing to submit data to the US regulator – Food and Drug Administration
Pfizer boss on run of good luck
Cantillon: Albert Bourla sale of shares on day of vaccine announcement entirely legitimate
EU agrees deal for 300m doses of BioNTech-Pfizer’s Covid vaccine
Deliveries expected to begin by the end of the year, subject to regulatory approval
Reasons to be optimistic for a Covid-19 vaccine by Christmas, says expert
Professor Luke O’Neill believes data is promising and treatments are getting better
Pfizer to seek FDA approval for Covid-19 vaccine in November
Company now a frontrunner in coronavirus vaccine race
Pfizer boss warns on risk of fast-tracking vaccines
Albert Bourla said he would never submit vaccine for authorisation before it was safe
US signs Covid $1.95bn vaccine deal with BioNTech
White House moves to secure up to 500m doses of promising vaccine candidate
Pfizer begins testing its Covid-19 vaccine on humans
Experimental trials will involve 360 patients in two age groups in bid to fast-track vaccine
Pfizer and Mylan to combine off-patent drugs businesses
Deal between makers of EpiPens and Viagra will create group with global annual revenues worth €18bn
Pfizer reports first-quarter profit that beats estimates
Strong vaccine and cancer drug sales help Merck top earnings expectations and send its shares higher
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices